Ascent Group’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-16,765
| Closed | -$474K | – | 531 |
|
|
2024
Q3 | $474K | Sell |
16,765
-9,300
| -36% | -$263K | 0.04% | 382 |
|
|
2024
Q2 | $498K | Buy |
26,065
+5,735
| +28% | +$110K | 0.04% | 358 |
|
|
2024
Q1 | $667K | Buy |
20,330
+550
| +3% | +$18K | 0.06% | 315 |
|
|
2023
Q4 | $622K | Buy |
19,780
+4,180
| +27% | +$132K | 0.06% | 312 |
|
|
2023
Q3 | $432K | Buy |
15,600
+700
| +5% | +$19.4K | 0.05% | 337 |
|
|
2023
Q2 | $430K | Sell |
14,900
-450
| -3% | -$13K | 0.05% | 329 |
|
|
2023
Q1 | $498K | Buy |
15,350
+300
| +2% | +$9.74K | 0.05% | 320 |
|
|
2022
Q4 | $423K | Sell |
15,050
-200
| -1% | -$5.62K | 0.05% | 322 |
|
|
2022
Q3 | $485K | Sell |
15,250
-1,250
| -8% | -$39.8K | 0.06% | 293 |
|
|
2022
Q2 | $561K | Buy |
16,500
+550
| +3% | +$18.7K | 0.07% | 284 |
|
|
2022
Q1 | $515K | Buy |
15,950
+900
| +6% | +$29.1K | 0.06% | 296 |
|
|
2021
Q4 | $333K | Buy |
+15,050
| New | +$333K | 0.04% | 364 |
|